Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Johnson & Johnson Is a Stock You Can Buy and Hold Forever

By Rachel Warren – Sep 29, 2021 at 8:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors searching for dependable returns should take a second look at this household name.

Johnson & Johnson (JNJ 0.08%) is hardly a new name to most. The company's stability and resilience in a variety of market conditions have revealed its true staying power for long-term buy-and-hold investors. In this segment of Backstage Pass, recorded on Sept. 20, 2021, Fool contributor and new investor Rachel Warren shares why she chose Johnson & Johnson as one of her first 10 stock buys. 

10 stocks we like better than Johnson & Johnson
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

They just revealed what they believe are the ten best stocks for investors to buy right now... and Johnson & Johnson wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks


*Stock Advisor returns as of September 17, 2021


Rachel Warren: So another great healthcare stock that I write about often. For me, like with these other big pharma companies. J&J, it's one of the oldest pharmaceutical companies around. It's been around for about a 135 years now. And, it's not one of those companies that is going to supercharge your portfolio overnight. 

But the thing that I love about it, and I think a lot of investors do, is it delivers that slow and steady and consistent growth in a variety of markets. It's one that you can really depend on for that. It does also pay a nice dividend, and it qualifies as a Dividend King, because it has consecutively every year raising its dividend for more than 50 years. It's current dividend is about 2.6%, last time I checked. 

Also, above the S&P 500's average. I think people mainly know J&J for their consumer health products. You've got those brands that everyone has in their house: Johnson's, Aveeno, Tylenol, Motrin. But I think that's actually something that's a big draw for a company if you look at it as a potential investor from the perspective of a consumer. You know, is this a company that like people use their products daily, are their products consistently in demand? 

That can be a really good indicator of whether a company is going to have real staying power in your portfolio. The company has not generally reported super-high annual earnings growth.

Generally it's more of those slow, steady growth returns. It was a little under 1% sales growth in 2020, and then continuing on that into 2021.

Rachel Warren owns shares of Johnson & Johnson. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy.

Stocks Mentioned

Johnson & Johnson Stock Quote
Johnson & Johnson
$178.88 (0.08%) $0.14

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.